4.7 Article

Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients

Journal

CLINICAL NUTRITION
Volume 39, Issue 6, Pages 1893-1899

Publisher

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.clnu.2019.08.003

Keywords

Resting energy expenditure; Malnutrition; Prognosis; Survival; Non-small cell lung cancer

Ask authors/readers for more resources

Background & aims: Metastatic non-small cell lung cancer (NSCLC) is the first cause of cancer death worldwide. Increased resting energy expenditure (REE) is frequent among cancer patients and may contribute to cancer cachexia. The aim of this study was to examine the prognostic value of increased REE in metastatic NSCLC patients. Methods: This observational study was conducted between June 2012 and November 2017 in the outpatient unit of the oncology department of Cochin hospital, Paris. Consecutive patients with newly diagnosed stage IV NSCLC underwent measurement of REE by indirect calorimetry before treatment initiation. Uni- and multivariate analysis of overall survival (OS, Cox models) included age, sex, smoking habit, histological subtype, performance status, body mass index, weight loss, albumin and CRP levels and the ratio of measured REE to the REE predicted by the Harris Benedict formula (mREE/pREE). Results: 144 patients were enrolled: mean age 64 years, 63% male, 90% non-squamous carcinoma, including 17% with ALK/EGFR alteration. In univariate analysis, tobacco consumption (p = 0.007), histomolecular subtype (p < 10(-3)), performance status (p = 0.04), weight loss (p < 10(-4)), albumin (p < 10(-4)), CRP (p = 0.001) and mREE/pREE ratio (>vs <= 120%: HR = 2.16, p < 10(-3)) were significant prognostic factors of OS. Median OS were 6.1 and 17.3 months in patients with mREE/pREE ratio > and <= 120%, respectively. In multivariate analysis, histomolecular subtype (non-squamous ALK/EGFR mutated vs squamous carcinoma: HR = 0.25, p = 0.006), weight loss (>vs <= 5%: HR = 1.98, p = 0.004), albumin (>= vs < 35 g/L: HR = 0.56, p = 0.02) and mREE/pREE ratio (> vs <= 120%: HR = 1.90, p = 0.004) were identified as independent prognostic factors. Conclusions: Elevated resting energy expenditure emerges as an independent prognostic factor in metastatic NSCLC. (C) 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available